Literature DB >> 5560921

Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat.

E Lorch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5560921     DOI： 10.1007/bf01212553

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  22 in total

1.  [OLIGOMYCIN-LIKE EFFECTS OF BIGUANIDES].

Authors:  G SCHAEFER
Journal:  Biochem Z       Date:  1963-09-19

2.  ENZYMATIC DETERMINATION OF GLUCOSE IN URINE BY AUTOMATION FOLLOWING RAPID REMOVAL OF INHIBITORS BY ION-EXCHANGE RESIN.

Authors:  J E LOGAN; D E HAIGHT
Journal:  Clin Chem       Date:  1965-03       Impact factor: 8.327

3.  The combined use of insulin, tolbutamide and biguanides in the treatment of diabetes mellitus. Clinical significance and experimental findings.

Authors:  W CREUTZFELDT; H D SOELING; Z ZARDAY
Journal:  Metabolism       Date:  1963-04       Impact factor: 8.694

4.  Enzymic determination of glucose and easily hydrolyzable glucose esters in blood.

Authors:  D WATSON
Journal:  Anal Biochem       Date:  1962-02       Impact factor: 3.365

5.  The mechanism of action of hypoglycemic guanidine derivatives.

Authors:  F A KRUGER; T G SKILLMAN; G J HAMWI; R C GRUBBS; N DANFORTH
Journal:  Diabetes       Date:  1960 May-Jun       Impact factor: 9.461

6.  Action of sodium salicylate and related compounds on tissue metabolism in vitro.

Authors:  T M BRODY
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

7.  Effect of biguanides on intestinal absorption of glucose.

Authors:  A Czyzyk; J Tawecki; J Sadowski; I Ponikowska; Z Szczepanik
Journal:  Diabetes       Date:  1968-08       Impact factor: 9.461

8.  [Changes in glucose tolerance and insulin level in healthy persons following administration of N1-butyl-biguanide retard].

Authors:  F Gomez; V Büber; J P Felber
Journal:  Klin Wochenschr       Date:  1969-12-15

9.  Studies on the site and mechanism of action of phenformin. I. Evidence for significant "nonperipheral" effects of phenformin on glucose metabolism in normal subjects.

Authors:  S L Hollobaugh; M B Rao; F A Kruger
Journal:  Diabetes       Date:  1970-01       Impact factor: 9.461

10.  Studies on the site and mechanism of action of phenformin. II. Phenformin inhibition of glucose transport by rat intestine.

Authors:  F A Kruger; R A Altschuld; S L Hollobaugh; B Jewett
Journal:  Diabetes       Date:  1970-01       Impact factor: 9.461
View more
  15 in total

1.  The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics.

Authors:  A Czyzyk; L G Heding; B Malczewski; E Miedzinska
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

2.  Inhibition of bile salt absorption by blood-sugar lowering biguanides.

Authors:  W F Caspary; W Creutzfeldt
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

3.  Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides.

Authors:  W F Caspary; I Zavada; W Reimold; U Deuticke; D Emrich; B Willms
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

4.  Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.

Authors:  W Lintz; W Berger; W Aenishaenslin; V Kutova; C Baerlocher; J P Kapp; R Beckmann
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

5.  Comparison of streptozotocin and alloxan-induced diabetes in the rat, including volumetric quantitation of the pancreatic islets.

Authors:  V Hoftiezer; A M Carpenter
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

6.  Inhibition of renal sugar and amino-acid transport by n-butyl-biguanide.

Authors:  J W Robinson; A L Luisier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Effects of metformin on insulin resistance after injury in the rat.

Authors:  K N Frayn
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

8.  Oxidation of an exogenous glucose load using naturally labelled 13C-glucose. Effect of butylbiguanide therapy in obese mildly diabetic subjects.

Authors:  P Lefebvre; A Luyckx; F Mosora; M Lacroix; F Pirnay
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

9.  Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats.

Authors:  A Handberg; L Kayser; P E Høyer; M Voldstedlund; H P Hansen; J Vinten
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

10.  [The effect of oral butyl-biguanide on oral glucose tolerance and renal glucose reabsorption in normal human subjects in vivo (author's transl)].

Authors:  E G Berger; V Brunner; H R Meier; P Moehr
Journal:  Klin Wochenschr       Date:  1978-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.